The Need
Each year, almost 35,000 people are diagnosed with HPV-related cancers – cancers that can largely be prevented through vaccination. While more than 60% of boys and girls in the U.S. get the first dose of the HPV vaccine, too many fail to get the full vaccination series. This means they are not getting the protection against cancer that the vaccine provides.
Our Solution
We work at the national, state, and community level to increase HPV vaccination uptake through education, awareness, and partnerships. Our initiatives seek to advance best practices, support clinic-based interventions, and increase collaboration and leadership among key partners to push the prioritization of the vaccine.
Work With Us
- Providers can access materials to champion quality improvement initiatives in their practice.
- Health systems can build workflows to make sure there are no missed opportunities.
- Public health professionals can use our HPV information and take action through the National HPV Vaccination Roundtable.
- Interested funding partners can support this important work by getting in touch with us.
Quick Facts
- The biggest predictor of HPV vaccination uptake is an effective recommendation from a health care provider.
- HPV vaccination is most effective when the series is completed between ages 9 and 12. All teenagers and young adults age 13 -26 who were not previously vaccinated should get vaccinated as soon as possible.
- Parents trust their health care provider to recommend the HPV vaccine.
- HPV vaccination is extremely effective. Research has shown the vaccine provides close to 100% protection against infections and precancers caused by the types of HPV in the vaccine.
Our Guideline
Access current guideline information from the American Cancer Society.
Featured Resources
Steps for Increasing HPV Vaccination in Practice
An action guide for implementing evidence-based interventions in the clinical setting.